Growblox Sciences Inc Stock Other OTC
Equities
US3998471029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.83M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -4M | EV / Sales 2022 | - |
Net Debt 2022 | 1.15M | Net Debt 2023 | 1.29M | EV / Sales 2023 | - |
P/E ratio 2022 |
-16.8
x | P/E ratio 2023 |
-1.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.78% |
Managers | Title | Age | Since |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
President | 54 | 14-06-09 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 54 | 14-06-09 | |
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
1st Jan change | Capi. | |
---|---|---|
+25.74% | 42.68B | |
-2.84% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.07% | 24.94B | |
-20.23% | 18.96B | |
+29.37% | 12.3B | |
-2.69% | 11.95B | |
-1.36% | 11.55B |